Evaluation of the correlation between scales determining disease severity in patients with moderate‐severe chronic plaque‐type psoriasis

Gündoğdu, Mustafa; Kundakçı, Nihal

doi:10.1111/jocd.13827

J of Cosmetic Dermatology

2020

DOI: 10.1111/jocd.13827

|View full text |Cite

Evaluation of the correlation between scales determining disease severity in patients with moderate‐severe chronic plaque‐type psoriasis

Mustafa Gündoğdu¹,

Nihal Kundakçı

Abstract: Background: Psoriasis is a chronic erythematous-squamous disease. The results of studies related with the correlation between methods used in determining disease severity are contradictory. Aims:The aim of this cross-sectional study is to evaluate the correlation between Psoriasis Area and Severity Index (PASI) and body surface area (BSA) involvement which are used to determine psoriasis severity and which are evaluated by the physician and Dermatology Life Quality Index (DLQI) and Psoriasis Disability Index (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Correlation between clinical severity and quality of life in moderate to severe psoriasis patients: Real-world evidence

Milidrag,

Safiye,

Gutic

et al. 2023

VOJNOSANIT PREGL

View full text Add to dashboard Cite

Background/Aim. Psoriasis is a chronic multisystem, inflammatory and immune-mediated dermatological disease of a relapsing nature. It does not only affect objective parameters such as skin and joint, with different intensity involvement with changes and the degree of changes but also significantly affects the health-related quality of life. The aim of the study was to determine the clinical severity and quality of life of patients with moderate to severe psoriasis and to examine the association between those parameters before and after the treatment. Methods. This cross-sectional study included 183 patients diagnosed with moderate to severe psoriasis. The severity of the clinical picture was determined by calculating Psoriasis Area and Severity Index (PASI) by a dermatologist, while the quality of life was assessed using Dermatology Life Quality Index (DLQI) questionnaire and the Psoriasis Life Stress Inventory (PLSI). Disease severity and quality of life were measured at the baseline visit and after 16th week of therapy. Results. The average PASI score at the beginning of therapy was 23.1?6.5, while after the 16 weeks, this value was 4.36?4.86. The DLQI score was 20.8?5.0 at the start of therapy and 6.20?6.16 after 16 weeks. The PLSI score was 35.37?8.84 initially and 12.75?12.82 after the 16 weeks of therapy. On the assessment of the correlation between the PASI and PLSI, the PASI score was found to be in a high positive correlation with the PLSI (r=0.702, ?<0.001) in the 16th week of therapy, but the correlation is moderate between the DLQI and PASI (r=0.683, ?<0.001). We failed to find any significant differences between PASI and DLQI scores (r=0.080, ?=0.284) and between PASI and PLSI scores (r=0.109, ?=0.140) in the baseline. Conclusion. Patients with severe psoriasis experience a significant reduction in their quality of life, accompanied by a high level of psychosocial stress. Observed improvements in quality of life have shown a moderate correlation, while lower levels of psychosocial stress have strongly correlated with the severity of the clinical presentation. This may indicate a complex interaction between psychological factors and physical health in patients with psoriasis.

show abstract

Correlation between clinical severity and quality of life in moderate to severe psoriasis patients: Real-world evidence

Milidrag,

Safiye,

Gutic

et al. 2023

VOJNOSANIT PREGL

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Evaluation of the correlation between scales determining disease severity in patients with moderate‐severe chronic plaque‐type psoriasis

Cited by 1 publication

References 16 publications

Correlation between clinical severity and quality of life in moderate to severe psoriasis patients: Real-world evidence

Correlation between clinical severity and quality of life in moderate to severe psoriasis patients: Real-world evidence

Contact Info

Product

Resources

About